Cotizaciones actuales de 2seventy bio, Inc. - Common Stock

Bolsa	Ticker	Moneda	Última operación	Precio	Variación diaria	Variación diaria %
NASDAQ	TSVT	USD	05.02.2025 22:00	2,74 USD	2,72 USD	0,74 %

Rendimiento

Día	Semana	Mes	3 meses	6 meses	1 año	5 años
0,00 %	4,58 %	-5,84 %	-41,70 %	-32,35 %	-51,50 %	-80,10 %

Perfil de la empresa para 2seventy bio, Inc. - Common Stock Acción

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Datos de la empresa

Nombre 2seventy bio, Inc. - Common Stock

Empresa 2seventy bio, Inc.

Símbolo TSVT

Sitio web https://www.2seventybio.com

Mercado principal

NASDAQ

ISIN US9013841070

Tipo de valor Acción

Sector Healthcare

Industria Biotechnology

CEO Mr. William D. Baird III, M.B.A.

Capitalización de mercado 129 Mio

País Estados Unidos de América

Moneda USD

Empleados 0,3 T

Dirección 60 Binney Street, 02142 Cambridge

Fecha de OPV 2021-11-03

ID Changes

Date	From	To
05.11.2021	TSVTV	TSVT

Ticker Symbols

Name	Symbol
NASDAQ	TSVT

More Shares

Investors who 2seventy bio, Inc. - Common Stock hold also have the following shares in their portfolio:

BQUE CT.VAU. 17-25 Bond

John Hancock Exchange-Traded Fund Trust John Hancock U.S. High Dividend ETF ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog